Drug interactions prescribed drugs

To explore the frequency of continuous use of over-the-counter drugs and the potential for harmful interactions between OTC drugs and prescribed drugs, a population-based interview survey was conducted in 10 477 subjects (231). Daily use of over-the-counter drugs was reported by 7% of the subjects and 4% of those who used over-the-counter drugs had taken combinations with potential for clinically significant interactions. Interactions were most common for NSAIDs such as ketoprofen (15% of keto-profen users), ibuprofen (10%), and aspirin (6%). Unfortunately, this study did not provide information on whether the potential interactions led to actual clinical problems. 

Morris, M. R. (1999). Antidepressants and drug interactions Prescriber beware. Journal of American College Health, 47(4), 191. 

The contents of this handbook should be utilized as a guide and in addition to sound clinical judgment. Consult full prescribing information and take into consideration each drug s pharmacokinetic profile, contraindications, warnings, precautions, adverse reactions, potential drug interactions, and monitoring parameters before use. 

Vigilance for drug-drug interactions is required because of the greater number of medications prescribed to elderly patients and enhanced sensitivity to adverse effects. Pharmacokinetic interactions include metabolic enzyme induction or inhibition and protein binding displacement interactions (e.g., divalproex and warfarin). Pharmacodynamic interactions include additive sedation and cognitive toxicity, which increases risk of falls and other impairments. 

Drug Name Generic/(Abbreviation)/ Trade Name Dosage Forms Commonly Prescribed Doses Dose Adjustments Food Restrictions Significant Adverse Events Drug Interaction Potential... 

Izzo, A. A. 8c Ernst, E. (2001). Interactions between herbal medicines and prescribed drugs a systematic review. Drugs, 61, 2163-75. 

In addition to food- or nutrient-based interactions in the metabolism of drugs, it has become quite clear in recent years that so-called dietary supplements including botanicals have the potential to participate in such interactions. The latter observation has special relevance because of the extensive use of such products worldwide ( 12 billion per year in the United States alone), their easy commercial availability (no prescription required), and their common use with prescribed drugs. Furthermore, many people consider such natural products to be safe and free of any bad effects (it should be pretty easy to recall many poisons... 

Training of prescribes but also all staff in the elderly care, Evidence Based Medicine, Computerised Prescriber Order Entry, Educational Outreach, inappropriate medications, documentation of clinical benefits, risk medications, drug interactions, pharmacological alterations with age. 

As already discussed, the same cannot be said for natural products used as dietary supplements. In most cases, those drugs have not heen subjected to the programs of testing required for FDA approval. As a result, products may pose a hazard to human health. Those hazards usually fall into one of four categories (1) the product may prevent a person from receiving other forms of FDA-approved medication that may he more beneficial to them (2) it may interact with other herbal medicines, prescribed drugs, and over-the-counter medications, with harmful effects (3) it may have no effect at all on a person s health or well-being or (4) it may actually cause harm to a person s health. 

Investigation of potential adverse interactions with drugs likely to be co-prescribed with the test drug may also be required. A generalised approach, such as the determination of effects on hepatic drug metabolising enzymes, may be sufficient, but in most cases, a number of drug-specific interaction studies will also be required. 

Therefore, there is potential for drug-drug interaction if patients are prescribed concomitant medication that interacts with these cytochrome P450 enzymes (Buzdar et al., 2002). 

---